CNDP1 and chronic kidney disease: In humans, a common leucine (CTG) repeat polymorphism in the signal peptide region of CNDP1 (exon 2) has been associated with reduced carnosinase activity [69] and correlated with a significantly reduced risk for diabetic nephropathy and slower progression of chronic kidney disease due to glomerulonephritis [70].